S-3,3'-bis((2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol
|
|
S-3,3'-bis((2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol 속성
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
그림문자(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
신호 어: | Warning | |||||||||||||||||||||||||||||||||||
유해·위험 문구: |
|
|||||||||||||||||||||||||||||||||||
예방조치문구: |
|
S-3,3'-bis((2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol C화학적 특성, 용도, 생산
S-3,3'-bis((2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol 준비 용품 및 원자재
원자재
준비 용품
S-3,3'-bis((2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol 공급 업체
글로벌( 21)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 |
sales@hzclap.com | CHINA | 6313 | 58 |
Adamas Reagent, Ltd. | 400-6009262 16621234537 |
zhangsn@titansci.com | China | 14113 | 59 |
Daicel Chiral Technologies (China)CO.,LTD | 021-50460086-9 15921403865 |
han_yajun@dctc.daicel.com | China | 6818 | 65 |
Tianjin Derchemist Science & Technology Co., Ltd. | 22-58627059 13920586291 |
zdcomcon@126.com | China | 2918 | 50 |
Bide Pharmatech Ltd. | 400-1647117 15221909166 |
product02@bidepharm.com | China | 41438 | 60 |
Shanghai Chiral bio-compound co., Ltd. | 021-5068 3667/17749785980/1029026415; 17749785980 |
1029026415@qq.com | China | 2790 | 58 |
LaaJoo | 021-60702684 18516024827 |
huang.jiayi@sinocompound.com | China | 2654 | 58 |
Greenherbs Science and Technology Development Co., Ltd. | 010-61136123 |
pub02@greenherbs.com.cn | China | 4049 | 58 |
Henan Alfachem Co.,Ltd. | 0371-0371-55051623 18137891487 |
2853979817@qq.com | China | 9960 | 58 |
Shanghai Anyinuo Biomedical Technology Co., Ltd. | 021-88888888 |
420970979@qq.com | China | 2806 | 58 |
S-3,3'-bis((2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol 관련 검색:
(R)-5,5',6,6',7,7',8,8'-Octahydro-3,3'-bis(4-nitrophenyl)-[1,1'-binaphthalene]-2,2'-diol
(R)-3,3'-DIMETHYL-1,1'-BINAPHTHALENE-2,2'-DIOL
S-3,3'-bis[4-(trifluoroMethyl)phenyl]-5,5',6,6',7,7',8,8'-octahydro-[1,1'-Binaphthalene]-2,2'-diol
R-3,3'-bis[4-(trifluoroMethyl)phenyl]-5,5',6,6',7,7',8,8'-octahydro-[1,1'-Binaphthalene]-2,2'-diol
R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol
S-3-3'-Bis(3,5-bis(methyl)phenyl)-1,1'-bi-2-naphthol
(R)-5,5',6,6',7,7',8,8'-Octahydro-3,3'-bis(4-methoxyphenyl)-[1,1'-binaphthalene]-2,2'-diol
R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2,2'-naphthol
R-5,5',6,6',7,7',8,8'-octahydro-3,3'-diphenyl-[1,1'-Binaphthalene]-2,2'-diol
R-3-3'-Bis(3,5-bis(methyl)phenyl)-1,1'-bi-2-naphthol
S-4-oxide-4-hydroxy-2,6-di-2-naphthalenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(1S)-3,3μ-Bis[2,4,6-tris(1-methylethyl)phenyl]-1,1μ-binaphthalene-2,2μ-diol
S-3,3'-bis(2,4,6-triMethylphenyl)-1,1'-Binaphthalene]-2,2'-diol
S-3,3'-Bis(3,5-bis(methyl)phenyl)-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
(S)-3,3'-Bis(3,5-diphenyl)phenyl-1,1'-binaphthyl-2,2'-diyl Hydrogen Phosphate
S-4-oxide-4-hydroxy-2,6-di-1-naphthalenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
S-4-oxide-4-hydroxy-2,6-bis(2,4,6-triMethylphenyl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(S)-TRIP, (11bS)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]dinaphtho[2,1-d:1μ,2μ-f]-1,3,2-dioxaphosphepin 4-oxide, (S)-3,3μ-Bis(2,4,6-triisopropylphenyl)-1,1μ-bi-2-naphthol cyclic monophosphate